Serum CA19-9

Pancreatic tumor marker (CA 19-9) is a pancreatic cancer-related antigen whose expression depends on the expression of the lewis blood group antigen. Lewis-negative CA19-9 tests are also negative. CA19-9 is sensitive and specific for the diagnosis of pancreatic cancer. It is 83.1% 73% 75% and the level of CA19-9 in patients with small pancreatic cancer is not high and less than 2cm. The positive rate of adenocarcinoma is only 60.7%, while the level of CA19-9 in patients with larger tumors is higher. Those who set 120kU / L higher than this value are highly suspected of pancreatic cancer. At the same time, they can also judge the prognosis. CA19-9 will return to normal after tumor resection. Serum critical value is 30kU / L. The prognosis is better. 9 increased significantly again so CA19-9 is an effective marker for pancreatic cancer.

The material in this site is intended to be of general informational use and is not intended to constitute medical advice, probable diagnosis, or recommended treatments.